Back to Trades
Other3
Kailera Therapeutics, Inc.
KLRA
Total Value
$NaN
Company Information
- Company Name
- Kailera Therapeutics, Inc.
- Ticker Symbol
- KLRA
- CIK
- 0002096997
Insider Information
- Role
- Insider
Filing Details
- Filing Date
- Apr 16, 2026
- Transaction Date
- Apr 16, 2026
- Accession Number
- 0001193125-26-159467
- Form Type
- 3
Footnotes
- (F1)Each share of Series B Preferred Stock of the issuer is convertible into one share of the issuer's common stock any time at the option of the reporting person. The issuer's Series B Preferred Stock has no expiration date.
- (F2)The securities reported herein are held directly by CPP Investment Board Private Holdings (4) Inc., a wholly-owned subsidiary of Canada Pension Plan Investment Board, and as such, Canada Pension Plan Investment Board is an indirect beneficial owner of such securities.